Immunosuppressants like topiramate modulate neurogenic inflammation and reduce neuronal excitability by inhibiting voltage-gated sodium channels and enhancing GABA-mediated inhibition. By dampening inflammatory processes and neuronal hyperactivity, these medications can help reduce the frequency and intensity of cluster headache episodes and provide prophylactic management of the condition.